Investors

As a global pharmaceutical company with a biotech mindset and a proven ability to provide new, life-changing therapies, Ipsen is a leading player in its core therapeutic areas.

Contact us

 

Craig Marks Adrien Dupin de Saint-Cyr
Vice-président, Relations avec les investisseurs Responsable des relations avec les investisseurs
+44 7584 349 193 +33 6 64 26 17 49

Contact us

Ipsen to acquire Albireo - webcast details

Ipsen to acquire Albireo - webcast details

Ipsen in Brief

Ipsen in Brief 2022

Discover Ipsen in two pages; our products and key figures, our objectives and our strategy.

Download

Registration document

2021 Universal Registration Document

This registration document contains forward-looking statements about Ipsen’s targets and forecasts, including the Annual Financial Report. The registration document provides a comprehensive information about the Company its activities, financial information, colleagues and legal information

Download

Research & Development pipeline

Ipsen R&D has a valuable pipeline encompassing both lifecycle management of our well-established products, and the development of innovative new molecules.

Learn more

Nous nous concentrons sur l’accélération de la croissance de nos ventes tout en améliorant notre rentabilité et la génération de flux de trésorerie, afin d’investir davantage dans le développement des affaires afin de construire un pipeline innovant et durable et de maintenir la dynamique de croissance de l’entreprise.


Aymeric Le Chatelier, CFO
© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023